HER2-positive breast cancer metastatic to intracranial meningioma: a case report.

  title={HER2-positive breast cancer metastatic to intracranial meningioma: a case report.},
  author={Mikkaela McCormack and C{\'e}sar Rosa and Michael K Murphy and Stephen B. Fox},
  journal={Journal of clinical pathology},
  volume={66 7},
The successful introduction of trastuzumab and other novel tyrosine kinase inhibitors (TKI) for treatment of HER2-positive breast carcinoma has resulted in lengthened survival for affected patients. In the context of this increased survival time, it has since emerged that patients who would otherwise have succumbed to the systemic progression of their disease have an increased propensity to develop metastases within the central nervous system (CNS) when compared with their HER2-negative… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
1 Citations
6 References
Similar Papers


Publications citing this paper.

Similar Papers

Loading similar papers…